HARP - Harpoon Therapeutics Inc - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

11.05M

Cash

45.56M

Avg Qtr Burn

-19.2M

Short % of Float

0.38%

Insider Ownership

9.54%

Institutional Own.

52.22%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
HPN328 (DLL3) +/- atezolizumab Details Solid tumor/s, Cancer, Small cell lung cancer	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
HPN217 (BCMA) Details Multiple myeloma	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
HPN536 (MSLN) Details Ovarian cancer, Solid tumor/s, Pancreatic cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
HPN424 (PSMA and CD3) Details Prostate cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.